SEC EDGAR CompanyFacts fact · reporting period
Lipella Pharmaceuticals Inc.: eps_basic
One fact, its scope and the complete path back to the official record.
Reported value
$-6{"per": "shares", "amount": -6.16, "concept": "us-gaap:EarningsPerShareBasic", "currency": "USD"}- Metric
- eps_basic
- Period
- 2023-01-01 – 2023-12-31
- Status
- current
- Source
- SEC EDGAR CompanyFacts
Provenance
Source licenseUS-PD-17USC105
Retrieved2026-08-19T12:52:47.412456+02:00
Raw response SHA-256
f7bde1a401b286c74a2fd824ee1df541…Official-identifier path
https://factanker.com/fact/sec/cik-0001347242/eps-basic/2023-12-31 (CIK, metric, reporting date)History
- supersedes {"per": "shares", "amount": -0.77, "concept": "us-gaap:EarningsPerShareBasic", "currency": "USD"} (evidence 0001753926-24-000403)
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.